Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities
Inotiv, Inc. (NOTV)
Company Research
Source: GlobeNewswire
WEST LAFAYETTE, Ind., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading Contract Research Organization (CRO) specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, and VUGENE, a multi-omics data analysis company providing advanced artificial intelligence (AI) and machine learning (ML) solutions for biomedical research, today announced a strategic collaboration designed to accelerate AI-assisted drug discovery and enhance data-driven insights across the drug development continuum. Through this partnership, Inotiv will integrate VUGENE’s cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division, enabling a more efficient and intelligent analysis of complex biological data. The collaboration will enhance Inotiv’s ability to interpret the full spectrum of epigenomic, proteomic, and other molecular dataset
Show less
Read more
Impact Snapshot
Event Time:
NOTV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NOTV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NOTV alerts
High impacting Inotiv, Inc. news events
Weekly update
A roundup of the hottest topics
NOTV
News
- Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities [Yahoo! Finance]Yahoo! Finance
- Inotiv Inc (NOTV) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Cybersecurity Challenges [Yahoo! Finance]Yahoo! Finance
- Inotiv (NASDAQ:NOTV) had its "buy" rating reaffirmed by analysts at Lake Street Capital.MarketBeat
- Inotiv, Inc. (NOTV) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business UpdateGlobeNewswire
NOTV
Earnings
- 8/6/25 - Miss
NOTV
Sec Filings
- 12/5/25 - Form 10-K
- 12/3/25 - Form 8-K
- 12/2/25 - Form 4
- NOTV's page on the SEC website